Score Overview
Explore the 2021 public Archive ranking →
Where Kazia Therapeutics Ltd ADR has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- KZIA
2004: 42.0% · 2018: 43.2% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 9.75 | — |
1 Year2025-09-29 | $ 7.47 | 30.52% |
5 Years2021-09-29 | $ 562.50 | -98.27% |
10 Years2016-09-29 | $ 394.00 | -97.53% |
20 Years2006-09-29 | $ 3.73K | -99.74% |
All Time1999-01-06 | $ 2.61K | -99.63% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | All Time1999-01-06 |
|---|---|---|---|---|---|---|
| Price | $ 9.75 | $ 7.47 | $ 562.50 | $ 394.00 | $ 3.73K | $ 2.61K |
| Return | — | 30.52% | -98.27% | -97.53% | -99.74% | -99.63% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in AUD
| Year | |||
|---|---|---|---|
| TTM | $ 42K | -$ 32M | $ 69M |
| 2025 | $ 42K | -$ 20M | $ 4M |
| 2024 | $ 2M | -$ 26M | $ 1M |
| 2023 | -$ 20M | $ 5M | |
| 2022 | $ 10K | -$ 25M | $ 7M |
| 2021 | -$ 8M | $ 27M | |
| 2020 | $ 988.11K | -$ 12M | $ 8M |
| 2019 | -$ 10M | $ 5M | |
| 2018 | -$ 6M | $ 5M | |
| 2017 | $ 8M | -$ 10M | $ 14M |
| 2016 | $ 4M | -$ 12M | $ 33M |
| 2015 | $ 89K | -$ 7M | $ 44M |
| 2014 | $ 87K | -$ 7M | $ 2M |
| 2013 | $ 1M | -$ 1M | $ 8M |
| 2012 | $ 1M | $ 1M | $ 8M |
| 2011 | $ 2M | -$ 6M | $ 6M |
| 2010 | $ 9M | -$ 12M | $ 15M |
| 2009 | $ 11M | -$ 18M | $ 33M |
| 2008 | $ 13M | -$ 20M | $ 34M |
| 2007 | $ 17M | -$ 20M | $ 39M |
| 2006 | $ 13M | -$ 16M | $ 33M |
| 2005 | $ 17M | -$ 12M | $ 47M |
| 2004 | $ 16M | -$ 12M | $ 58M |
| 2003 | $ 32M | -$ 10M | $ 30M |
| 2002 | $ 19M | -$ 14M | $ 39M |
| 2001 | $ 58M | -$ 42M | $ 61M |
| 2000 | $ 26M | -$ 13M | $ 28M |
| IPO1999 | $ 19M | -$ 17M | $ 29M |
Kazia Therapeutics Ltd ADR fundamental performance
Between 2015 and 2025, revenue declined from $ 89K to $ 42K and net income went from -$ 7M to -$ 20M. Revenue increased in 3 of those 10 years; net income in 5.
Across Kazia Therapeutics Ltd ADR's full reported history, from 1999 to 2025, revenue declined from $ 19M to $ 42K and net income went from -$ 17M to -$ 20M. Revenue increased in 40% of the years measured; net income in 52%.
Kazia Therapeutics Ltd ADR currently holds a 20-year HDB Score of 2.5 out of 10. How the HDB Score is calculated.
Membership
Continue KZIA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
